COVID-19 is a respiratory illness caused by the severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2), a virus from the coronavirus subfamily. COVID-19 is a highly infectious disease and can spread through human-to-human transmissions, such as close contact with infected individuals or by being in enclosed spaces where contaminated droplets or airborne particles circulate. For more and updated information on COVID-19 transmission, please click here.

Symptoms may begin 1-14 days after exposure to the virus, and can include fever, cough, breathing difficulties, fatigue, and loss of smell and taste. Most people with COVID-19 exhibit mild to moderate symptoms, while some exhibit no noticeable symptoms at all.

However, there are people who will develop severe symptoms from COVID-19, with outcomes that can include hospitalization, intensive care, post-sickness conditions, and even death. Individuals infected with COVID-19 can remain contagious for up to 20 days, and can spread the virus even if they themselves do not develop symptoms. For more and updated information on COVID-19 symptoms, please click here.

People most at risk are older people aged 60 years and over, as well as individuals of any age with underlying medical conditions such as high blood pressure, heart or lung disease, diabetes, or cancer. However, anyone can get sick with COVID-19 and become seriously ill, even people considered healthy and low risk. For more and updated information on groups at increased risk of severe illness due to COVID-19, please click here.

INDICAID^® is PHASE Scientific’s brand of COVID-19 Rapid Antigen At-Home Test. It is a fast, easy and cost-effective way to test yourself (or family members & friends) to see if you have been infected with SARS-CoV-2.

It is a non-invasive test that involves a shallow nasal swab for collecting the nasal sample, which provides improved comfort compared with many other rapid antigen tests.

Also, you can test at-home or ‘on the go’ and obtain results in about 20 minutes.

This test can be administered with no equipment or training, and results can be developed in as fast as 20 minutes. The test has high sensitivity and can detect lower viral load samples against competitive products. This test has been granted Emergency Use Authorization (EUA) by the United States Food and Drug Administration.

Our test package contains an Instructions for Use (IFU), a Quick Reference Guide, plus 2 or 12 sets of sterile nasal swabs, buffer solution vials and lateral flow test devices(depends on your choice of package sizes).

If your test result is negative, you should discuss with your healthcare provider whether an additional test is necessary and if you should continue isolating at home. There is a higher chance of false negative results with antigen tests than with laboratory-based molecular test. This means that there is a higher chance this test will give you a negative result when you have COVID-19 than a molecular test would.

Anyone age 14 or older can perform INDICAID^® COVID-19 Rapid Antigen At-Home Test on their own, and an adult (age 18 or older) should collect the sample from children ages 2 to 13 years old and then perform the test on behalf of the child. Note that this test is not approved for use with children under the age of 2.

We recommended that you use the INDICAID^® COVID-19 Rapid Antigen At-Home Test if you are experiencing COVID-19 type symptoms, such as fever, cough, breathing difficulties, fatigue, and/or loss of smell or taste.

We also suggest you test if you have been exposed to someone testing positive for COVID-19 (even if you are ‘asymptomatic’).

Testing is also useful before or after travel, or even just to provide you and your family ‘peace of mind’ as you go back to the office, back to school, or attend events with larger groups of people.

Yes, our INDICAID^® COVID-19 Rapid Antigen At-Home Test is approved for detection of asymptomatic infections.

If you are asymptomatic and your test result is ‘negative’, then we suggest performing a 2nd test in 24 to 48 hours (after the initial test) to make sure you are still testing ‘negative’. If you test a 2nd time and it still provides a ‘negative’ result, then it is probable that you did not contract COVID-19.

The buffer solution contains two different reagents that are hazardous ingredients that should not be ingested. Please refer to the Instructions for Use (IFU) for more information.

If you think someone swallowed some of the extraction buffer, please seek medical advice at 1-800-222-1222 or use the following link: www.poison.org/contact-us

If the extraction buffer contacts the skin or eye, immediately wash the affected area with plenty of running water. If the irritation persists, please seek medical advice at 1-800-222-1222.

Store the tests between 36-86℉ (i.e. 2-30°C) until you are ready to use the test, and then make sure the test components are at room temperature when you are ready to conduct the test.

Negative: A line appears in the region (C)

Positive: A line appears in regions (C) and (T)

Invalid Result: No line appears in the region (C)

A positive result means that, it is very likely that you have COVID-19 because proteins from the virus that causes COVID-19 were found in your sample. You should self-isolate from others and contact healthcare provider for medical advice about your positive result. Your healthcare provider will work with you to determine how best to care for you based on your test result(s), medical history, and symptoms.

A negative test result indicates that antigens from the virus that causes COVID-19 was not found in your sample. If you have symptoms, you likely do not have COVID-19. If you do not have symptoms and you receive a second negative result 24 to 48 hours after your first negative result, then you are likely not infected with COVID-19.

If no control line shows up on the test, the result is invalid (even if any test line shows up). An invalid result means the test was not able to tell if you have COVID-19 or not. If the test is invalid, a new swab should be used to collect a new nasal specimen and the test should be run again, using all new test components.